摘要:
A cooling system is provided for a battery unit and a motor control unit of a hybrid vehicle. Preferred cooling systems can have a compact structure and can efficiently cool the battery unit and the motor control unit mounted in a vehicle using air, thus ensuring stable operation of the battery unit and the motor control unit and maximizing utilization of space in the vehicle.
摘要:
A cooling system is provided for a battery unit and a motor control unit of a hybrid vehicle. Preferred cooling systems can have a compact structure and can efficiently cool the battery unit and the motor control unit mounted in a vehicle using air, thus ensuring stable operation of the battery unit and the motor control unit and maximizing utilization of space in the vehicle.
摘要:
An independently suspended, driven axle shaft set in which the axle shafts are asymmetric with respect to each other, wherein the asymmetry provides mitigation of powerhop. The asymmetric axle shafts are asymmetrically selected such that the relative torsional stiffness therebetween is different by a ratio substantially between about 1.4 to 1 and about 2.0 to 1. The asymmetry may be provided by any known modality that alters torsional stiffness and is compliant with operational load demands of the axle shafts, as for example the axle shafts having the same length, but differing cross-sectional diameters; or by the axle shafts having the same cross-sectional diameters, but differing lengths; or a combination thereof.
摘要:
The present invention relates to compounds and methods for the prevention or treatment of infections by negative strand RNA viruses, such as influenza virus and measles virus, wherein said compounds delay or inhibit viral replication by modulating the level or activity of a polypeptide involved in the synthesis or degradation of sphingosine-1-phosphate (S1P) in a cell, tissue, or subject. The methods involve administration of one or more compounds which modulate the level of gene expression, where the gene encodes a polypeptide involved in regulating the metabolic level of S1P, or modulate the level or activity of a polypeptide involved in regulating the metabolic level of S1P, such as sphingosine kinase (SK) and S1P lyase (SPL). Exemplary methods are directed towards reducing the level of SW by reducing the level or activity of one or more SKs, increasing the level or activity of one or more SPLs, or a combination of both steps.